Interaction of U-69,593 with μ-, ∂- and k-opioid binding sites and its analgesic and intestinal effects in rats

[1]  S. Iversen,et al.  Handbook of Psychopharmacology , 1988, Springer US.

[2]  D. Verotta,et al.  Differential postnatal development of mu-, delta- and kappa-opioid binding sites in rat brain. , 1987, Brain research.

[3]  H. Kim,et al.  Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes. , 1986, Life sciences.

[4]  P. Ferretti,et al.  Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. , 1986, The Journal of pharmacology and experimental therapeutics.

[5]  M. Skingle,et al.  Effect of β‐funaltrexamine on opioid side‐effects produced by morphine and U‐50, 488H , 1985, The Journal of pharmacy and pharmacology.

[6]  J. Mccall,et al.  [3H]U-69593 a highly selective ligand for the opioid κ receptor , 1985 .

[7]  S. Tam,et al.  (+)-[^3H]SKF-10,047, (+)[^3H]ethylketocyclazocine, μ,κ,δ and phencyclidine binding sites in guinea pig brain membranes , 1985 .

[8]  A. Tavani,et al.  The interaction of the two isomers of the opioid benzodiazepine tifluadom with μ-, δ-, and k-binding sites and their analgesic and intestinal effects in rats , 1985, Neuropeptides.

[9]  A. Tavani,et al.  Differential postnatal development of mu-, delta-and chi-opioid binding sites in mouse brain. , 1985, Brain research.

[10]  R. Lahti,et al.  3H-SKF10047 receptor binding studies. Attempts to define the opioid sigma receptor , 1984, Neuropeptides.

[11]  A. Tavani,et al.  Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent rats. , 1984, Life sciences.

[12]  V. Hruby,et al.  Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. , 1984, The Journal of pharmacology and experimental therapeutics.

[13]  V. Hruby,et al.  Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids. , 1984, The Journal of pharmacology and experimental therapeutics.

[14]  A. Tavani,et al.  The opioid κ‐selective compound U−50,488H does not inhibit intestinal propulsion in rats , 1984 .

[15]  P. Ferretti,et al.  Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut. , 1983, Gastroenterology.

[16]  T. Burks,et al.  The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse. , 1983, The Journal of pharmacology and experimental therapeutics.

[17]  A. Tavani,et al.  Agonist and antagonist properties of some benzomorphans on nociceptive reaction and intestinal transit in rats. , 1983, Life sciences.

[18]  R. Lahti,et al.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist. , 1983, The Journal of pharmacology and experimental therapeutics.

[19]  R. Boigegrain,et al.  Kappa binding sites in guinea-pig brain membranes: evidence for a dynorphin-resistant subtype. , 1983, Life sciences.

[20]  A. Tavani,et al.  Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine. , 1982, Life sciences.

[21]  H. Kosterlitz,et al.  SPECTRUM OF THE μ‐, δ‐ AND κ‐BINDING SITES IN HOMOGENATES OF RAT BRAIN , 1982 .

[22]  B. Attali,et al.  Evidence for multiple “kappa” binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord , 1982, Neuropeptides.

[23]  P. Molinoff,et al.  Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. , 1981, Life sciences.

[24]  B. Morgan,et al.  Analogues of β-LPH61–64 posessing selective agonist activity at μ-opiate receptors , 1981 .

[25]  P. Ferretti,et al.  Morphine is most effective on gastrointestinal propulsion in rats by intraperitoneal route: evidence for local action. , 1980, Life sciences.

[26]  L. Terenius,et al.  ASSESSMENT IN THE GUINEA‐PIG ILEUM AND MOUSE VAS DEFERENS OF BENZOMORPHANS WHICH HAVE STRONG ANTINOCICEPTIVE ACTIVITY BUT DO NOT SUBSTITUTE FOR MORPHINE IN THE DEPENDENT MONKEY , 1975, British journal of pharmacology.

[27]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.